PYDC5 (Gene)

Description:pyrin domain containing 5

Predicted to enable double-stranded DNA binding activity. Involved in cellular response to interferon-beta; cellular response to virus; and negative regulation of protein-containing complex assembly. Predicted to be part of AIM2 inflammasome complex. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View PYDC5's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with PYDC5.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using PYDC5.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for PYDC5.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PYDC5.

Results found

Linked to

	Label	Description
	GSE212330 azacitidine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 gemcitabine 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 2 V 5 GEMCITABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 7 V 4 DECITABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE212330 1 V 0 AZACITIDINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE215461 0 V 1 TOPOTECAN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE168097 epinephrine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE118816 Myo1c knockdown podocyte 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE168097 3 V 2 EPINEPHRINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

GSE212330 azacitidine 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE165548 gemcitabine 2 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE165548 2 V 5 GEMCITABINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE218060 7 V 4 DECITABINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE212330 1 V 0 AZACITIDINE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE215461 0 V 1 TOPOTECAN HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE168097 epinephrine 3 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE118816 Myo1c knockdown podocyte 0 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE168097 3 V 2 EPINEPHRINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.